.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Accenture
Johnson and Johnson
Chubb
Moodys
Argus Health
Colorcon
Daiichi Sankyo
McKesson
UBS

Generated: February 19, 2018

DrugPatentWatch Database Preview

Patents Expiring in 2034

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Abraxis BioscienceABRAXANEpaclitaxelFOR SUSPENSION;IV (INFUSION)021660-001Jan 7, 2005RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF PANCREATIC CANCER
Gilead Sciences IncEPCLUSAsofosbuvir; velpatasvirTABLET;ORAL208341-001Jun 28, 2016RXYesYes➤ Sign Up➤ Sign UpY
Sanofi Aventis UsAUBAGIOteriflunomideTABLET;ORAL202992-002Sep 12, 2012RXYesYes➤ Sign Up➤ Sign UpTREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHILE MANAGING THE RISK OF TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION BY LIMITING THE ROSUVASTATIN DOSE TO NO MORE THAN 10MG AND/OR ADMINISTERING ABOUT HALF THE NORMAL DOSE
Sanofi Aventis UsAUBAGIOteriflunomideTABLET;ORAL202992-001Sep 12, 2012RXYesNo➤ Sign Up➤ Sign UpTREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS WHILE MANAGING THE RISK OF TERIFLUNOMIDE AND ROSUVASTATIN INTERACTION BY LIMITING THE ROSUVASTATIN DOSE TO NO MORE THAN 10MG AND/OR ADMINISTERING ABOUT HALF THE NORMAL DOSE
AllerganRESTASIS MULTIDOSEcyclosporineEMULSION;OPHTHALMIC050790-002Oct 27, 2016RXYesYes➤ Sign Up➤ Sign UpY
Qol MedclSUCRAIDsacrosidaseSOLUTION;ORAL020772-001Apr 9, 1998RXYesYes➤ Sign Up➤ Sign UpYY
Upsher-smith LabsVOGELXOtestosteroneGEL, METERED;TRANSDERMAL204399-003Jun 4, 2014BXRXNoNo➤ Sign Up➤ Sign UpYMETHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Upsher-smith LabsVOGELXOtestosteroneGEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo➤ Sign Up➤ Sign UpYMETHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Upsher-smith LabsVOGELXOtestosteroneGEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo➤ Sign Up➤ Sign UpYMETHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
Upsher-smith LabsVOGELXOtestosteroneGEL;TRANSDERMAL204399-002Jun 4, 2014AB2RXNoNo➤ Sign Up➤ Sign UpYMETHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Medtronic
Queensland Health
Citi
Harvard Business School
Federal Trade Commission
Julphar
Cerilliant
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot